Views & Analysis

Debates & Insight
How to effectively engage in the rare disease space
Sponsored

How to effectively engage in the rare disease space

Engaging with the relevant healthcare stakeholders for pharma company sales forces increasingly requires on-going adapatation and new skills, but engaging in the rare disease space is even hard

Debates & Insight
Outcomes shape the new payer networks for pharma
Sponsored

Outcomes shape the new payer networks for pharma

The definition of the payer and the way in which healthcare spending decisions are made is changing, as complex networks of payers and clinicians become the new stakeholders with which the pharma i